7 Insurance-Covered Programs for Chronic Migraine in 2026

Chronic migraine, defined by the ICHD-3 as 15 or more headache days per month for at least three months, affects about 1% of adults in the United States. That translates to more than 3 million people living with near-daily headaches that interfere with work, sleep, relationships, and quality of life.

The good news: insurance coverage for chronic migraine treatment has expanded significantly. From behavioral coaching programs to biologic therapies and FDA-cleared devices, people with chronic migraine now have more covered options than at any point in the past decade. This guide breaks down seven evidence-based programs and treatments that many insurance plans cover, starting with approaches that target chronic migraine at its neurological source.

Key Takeaways

• Chronic migraine involves changes in how the brain processes pain, making behavioral and brain-first approaches a valuable part of treatment alongside medication.
• The American Headache Society now considers CGRP-targeting therapies a first-line preventive option, removing the prior requirement to fail other medications first.
• Behavioral therapies like CBT and relaxation training may reduce migraine frequency in adults, with zero medication side effects.
• Lin Health offers a coach-led behavioral migraine program that is covered by most insurance plans, with patients typically paying nothing out of pocket.
• Talk with a neurologist or headache specialist before changing your treatment plan, as the right combination depends on your migraine pattern, medical history, and goals.

1. Lin Health: Coach-Led Behavioral Medicine Program

Lin Health is a brain-first behavioral coaching program designed for people living with chronic pain and persistent symptoms, including chronic migraine. Rather than managing symptoms through medication alone, it works by retraining how the nervous system processes and responds to pain signals.

How It Works

Lin Health pairs each participant with a trained recovery coach who delivers weekly sessions via telehealth, supplemented by an app with structured learning modules and between-session exercises. The program draws on modalities including cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and somatic tracking techniques tailored for migraine, all protocolized by clinical experts into a guided curriculum.

The core principle: after months or years, chronic migraine can involve neural pain pathways that keep the pain alarm firing even between acute triggers. Fear of the next attack, disrupted sleep, and avoidance of normal activities can reinforce this cycle. Lin Health's approach is based on findings from neuroplastic pain research, targeting the thoughts, emotions, and behaviors that sustain it.

Evidence

Behavioral interventions for migraine, including CBT and relaxation training, may reduce headache frequency in adults based on a 2025 systematic review of 50 trials. The strength of evidence is rated low, but the American Headache Society's consensus statement places these approaches among the recommended options for migraine prevention, including for people who are pregnant or unable to tolerate medications.

Mindfulness-based approaches have also improved disability outcomes, quality of life, and self-efficacy in a randomized trial of adults with 4 to 20 migraine days per month.

Lin Health applies these behavioral and neuroplastic pain principles in a structured, coached format. It is not the therapy of record in any specific migraine trial, but its modalities are grounded in the same evidence base.

Insurance Coverage

Lin Health is covered by most major insurance plans. High-coverage states include Colorado, Texas, Florida, California, and New York, with some coverage available in additional states. Patients typically pay zero out of pocket. After signing up, a team member calls the same day to check insurance eligibility, and wait times are short.

Who May Benefit

People with chronic migraine who want a non-medication approach, have experienced side effects from preventive medications, or are looking for structured professional coaching. It is especially relevant for those who have tried multiple treatments without lasting relief and want to address the behavioral and neuroplastic factors that may be sustaining their migraine cycle.

2. CGRP-Targeting Therapies (Monoclonal Antibodies and Gepants)

CGRP-targeting therapies represent one of the most significant advances in migraine prevention in the past decade. The American Headache Society now considers them a first-line preventive option, removing the earlier requirement to fail other medication classes first.

How They Work

Calcitonin gene-related peptide (CGRP) plays a central role in migraine pain signaling. These therapies either block CGRP itself or its receptor:

• Monoclonal antibodies (injections or infusions): erenumab (Aimovig), fremanezumab (Ajovy), galcanezumab (Emgality), eptinezumab (Vyepti, IV infusion)
• Gepants (daily oral tablets): atogepant (Qulipta), rimegepant (Nurtec ODT, also used for acute treatment)

Evidence

In adults with chronic migraine, CGRP monoclonal antibodies reduce monthly migraine days, with a meaningful proportion of patients achieving at least a 50% reduction based on a Bayesian network meta-analysis. Atogepant met all trial endpoints in its phase 3 chronic migraine trial, earning FDA approval for this indication in 2023.

Insurance Coverage

More than half of commercial insurance plans no longer require prior failure of other preventive classes before covering a CGRP therapy, based on late-2025 coverage data. However, some plans still use step therapy (requiring a trial of one or two oral preventives first), prior authorization based on migraine frequency, or prior authorization based on severity. Manufacturer copay assistance programs are available for most agents and can significantly reduce out-of-pocket costs for commercially insured patients.

Who May Benefit

Adults with chronic migraine who want a targeted preventive therapy with a generally favorable side-effect profile. CGRP therapies are among the most studied specifically for chronic migraine prevention and can be combined with other approaches, including behavioral programs.

3. OnabotulinumtoxinA (Botox) Injections

OnabotulinumtoxinA is the only botulinum toxin FDA-approved for chronic migraine prevention, a distinction it has held since 2010. It is not approved for episodic migraine.

How It Works

A headache specialist administers 31 injections across seven head and neck muscle areas every 12 weeks. The mechanism in migraine is not fully understood, but it is believed to reduce pain signaling in peripheral sensory neurons and inhibit the release of pain-related neuropeptides.

Evidence

The pivotal clinical program showed reduced headache days compared to placebo over 56 weeks. Adverse events were more common than placebo, most commonly neck pain and injection-site discomfort. OnabotulinumtoxinA remains a current recommendation from the American Headache Society for chronic migraine.

Insurance Coverage

Coverage for onabotulinumtoxinA for chronic migraine is well-established across most commercial and Medicare plans. Plans typically require a confirmed chronic migraine diagnosis (15+ headache days per month documented over 3+ months) and often documentation that at least two oral preventive medications were tried. Treatments are administered in a neurologist's or headache specialist's office.

Who May Benefit

Adults with confirmed chronic migraine who have not responded adequately to oral preventives or who experience intolerable side effects from those medications. Some patients prefer the every-12-week injection schedule over daily oral medication.

4. Comprehensive Multidisciplinary Headache Programs

Some medical centers offer intensive, multidisciplinary headache programs that combine neurological care, behavioral therapy, physical therapy, medication management, and patient education under one roof. Examples include programs at academic headache centers and specialty neurology clinics such as those affiliated with Mayo Clinic and other regional headache centers.

How They Work

These programs bring together headache neurologists, pain psychologists, physical therapists, and sometimes dietitians to create an individualized plan. Sessions may run over several days to weeks depending on format (intensive outpatient vs. longitudinal). The goal is to address chronic migraine from multiple angles simultaneously rather than cycling through single-modality treatments one at a time.

Evidence

Clinical guidelines from the American Headache Society and other organizations support multidisciplinary approaches for refractory chronic migraine. Evidence for specific bundled programs comes primarily from the well-studied individual components (behavioral therapy, physical rehabilitation, medication optimization) rather than randomized trials of the combined format.

Insurance Coverage

Coverage varies significantly by insurer and program. Most programs bill through a combination of neurology, behavioral health, and physical therapy benefits. Intensive outpatient programs at large academic centers often have dedicated insurance coordination teams to help with pre-authorization. Geographic access is a meaningful barrier, as these programs are concentrated in larger metro areas and academic medical centers.

Who May Benefit

People with chronic migraine who have not responded to single-modality treatments and need a coordinated, multi-angle approach. These programs are especially suited for complex cases with medication overuse headache, multiple comorbidities, or prolonged disability.

5. Oral Preventive Medications

Oral preventives have been the backbone of migraine prevention for decades. Several drug classes carry Level A evidence for episodic migraine prevention, and while chronic-migraine-specific trial data are thinner for many of these agents, they remain widely prescribed and covered.

How They Work

Different classes work through different mechanisms:

• Beta-blockers (propranolol, metoprolol, timolol): reduce sympathetic nervous system activity
• Antiepileptics (topiramate, divalproex/valproate): modulate neural excitability
• Antidepressants (amitriptyline, venlafaxine): affect serotonin and norepinephrine signaling
• ARBs (candesartan): may reduce cortical spreading depression

Evidence

A network meta-analysis found that topiramate and valproate improve responder rates for migraine prevention compared to placebo, with propranolol also demonstrating significant frequency reduction. The ACP's migraine prevention guideline provides a current framework for selecting among these options.

Insurance Coverage

Most oral preventives are available as generics, making them among the most affordable and widely covered migraine treatments. Copays are typically low, and prior authorization is rarely required. This accessibility is why some insurers still list oral preventives as a first step before approving newer therapies.

Who May Benefit

Adults looking for an affordable, well-established preventive option. Oral preventives are often the initial step in a chronic migraine treatment plan, though side effects can limit long-term adherence. Common concerns include weight changes, cognitive slowing with topiramate, sedation with amitriptyline, and mood effects.

6. Behavioral Therapy Programs (CBT with a Therapist)

Working one-on-one with a psychologist or behavioral health therapist trained in headache management is an evidence-based option for chronic migraine that many insurance plans cover under behavioral health benefits.

How They Work

Therapy programs for migraine typically use CBT, relaxation training, or stress management techniques. Sessions focus on identifying and modifying thought patterns and behaviors that may worsen migraine frequency or intensity, including catastrophizing, avoidance of activity, and poor stress regulation. Biofeedback, which teaches patients to control physiological responses like muscle tension, is sometimes included, though biofeedback alone has insufficient evidence for migraine prevention in adults.

Evidence

A 2025 systematic review of 50 adult trials found that CBT, relaxation training, and mindfulness may reduce migraine frequency at low strength of evidence. The American Headache Society's consensus statement recommends behavioral treatment as part of comprehensive migraine management, particularly for patients who are pregnant, planning pregnancy, or unable to tolerate medications.

Insurance Coverage

Most commercial plans and many state Medicaid programs cover behavioral therapy under mental or behavioral health benefits. The main access barrier is finding a therapist trained specifically in headache management. Headache-focused behavioral therapists are relatively scarce, and wait times can stretch to months in some areas.

Who May Benefit

People who prefer non-medication approaches, are pregnant or breastfeeding, experience anxiety or stress as a significant migraine trigger, or want to complement their medication regimen with behavioral tools. For those who face long wait times or limited local access, programs like Lin Health may offer a more accessible alternative with shorter wait times and structured coaching.

7. FDA-Cleared Neuromodulation Devices

Several non-invasive neuromodulation devices have received FDA clearance for migraine treatment, offering a drug-free, at-home option for prevention and acute relief.

How They Work

These devices deliver electrical or magnetic stimulation to specific nerves or brain regions:

• Cefaly (external trigeminal nerve stimulation): worn on the forehead, stimulates the supraorbital branch of the trigeminal nerve
• Nerivio (remote electrical neuromodulation): worn on the upper arm, activates conditioned pain modulation pathways
• gammaCore (non-invasive vagus nerve stimulation): applied to the neck, stimulates the vagus nerve
• SAVI Dual and Relivion: newer devices with FDA clearance for migraine

Evidence

The International Headache Society issued conditional device recommendations, noting that the quality of evidence ranges from very low to moderate. These are weak recommendations, meaning the devices may be reasonable for some patients but the evidence base is still limited. Notably, gammaCore did not meet its primary endpoint in the chronic migraine trial.

Insurance Coverage

Insurance coverage for neuromodulation devices is inconsistent. Some plans cover Cefaly with a prescription and prior authorization. Nerivio and gammaCore coverage varies widely by plan. Manufacturer subscription models (monthly device or treatment-session fees) can add out-of-pocket costs even with partial insurance coverage. Checking with your specific insurer before purchasing is important.

Who May Benefit

Adults who want a non-medication, non-injection option with few systemic side effects. Devices may work as an add-on to other preventive strategies rather than a standalone treatment, and they are worth discussing with a headache specialist for patients who have not tolerated medications well.

How Lin Health Helps with Chronic Migraine

Chronic migraine can develop when the brain's pain-processing pathways become sensitized over time, creating a cycle where the nervous system keeps firing pain signals even between acute triggers. Fear of the next attack, disrupted sleep, stress, and avoidance of normal activities can all reinforce this pattern.

Lin Health's program is designed to break these cycles. Recovery coaches guide participants through structured behavioral modules covering CBT, acceptance and commitment therapy, and somatic tracking techniques. Sessions happen weekly via telehealth, with an app providing learning and practice materials between sessions.

What sets Lin Health apart from other options on this list:

• Coach-led, not self-guided: every participant works with a trained recovery coach, unlike apps or workbooks alone
• Insurance-covered: most plans accepted in CO, TX, FL, CA, NY, and additional states, with patients typically paying zero out of pocket
• Short wait times: a team member calls the same day after sign-up to verify coverage
• No medications: entirely behavioral, meaning no drug interactions or side effects
• Complements other treatments: Lin Health can be used alongside CGRP therapies, Botox, or oral preventives

Behavioral approaches for migraine carry a recommendation from AHS and are particularly valuable for people who have tried medication-based treatments and want to address the factors that sustain the pain cycle. Lin Health's approach is based on findings from neuroplastic pain research and applies these principles in a format that is accessible, covered by insurance, and guided by a real person.

If you have been managing chronic migraine with medications alone and want to address the behavioral and neuroplastic patterns that may be keeping the cycle going, Lin Health may help. Most patients pay zero out of pocket, and the first call typically happens the same day.

FAQ

What is the difference between episodic and chronic migraine?

Episodic migraine involves fewer than 15 headache days per month. Chronic migraine is 15+ headache days monthly for at least three months, with at least 8 of those days meeting full migraine criteria. Chronic migraine often requires a different treatment approach than episodic.

Does insurance cover CGRP injections for migraine?

Most commercial plans now cover at least one CGRP therapy, and over half no longer require prior failure of other preventive classes. Prior authorization is still common. Check with your insurer and ask about manufacturer copay assistance programs.

Can behavioral therapy help reduce chronic migraine frequency?

CBT, relaxation training, and mindfulness-based approaches may reduce migraine frequency in adults, based on a 2025 systematic review of 50 trials. They are especially useful for people who cannot take preventive medications or want to address stress and behavioral triggers alongside medical treatment.

How does Lin Health's chronic migraine program work?

Lin Health provides weekly telehealth sessions with a recovery coach, combined with app-based learning modules. The program applies CBT, acceptance and commitment therapy, and somatic tracking techniques to address the neuroplastic and behavioral patterns that may sustain chronic migraine.

Is Botox covered by insurance for chronic migraine?

OnabotulinumtoxinA (Botox) is covered by most plans for chronic migraine specifically, not episodic migraine. Plans typically require a confirmed diagnosis and documentation that oral preventives were tried first. Injections are administered every 12 weeks by a specialist.

Are neuromodulation devices covered by insurance?

Coverage is inconsistent. Some plans cover Cefaly with a prescription and prior authorization. Nerivio and gammaCore coverage varies widely. Check your plan before purchasing, as subscription fees may apply even with partial coverage.

Can I combine multiple chronic migraine treatments?

Yes. Many headache specialists recommend combining approaches. A CGRP therapy for prevention plus a behavioral coaching program is one common combination. Discuss any treatment changes with your neurologist to ensure a coordinated plan.

This article is for informational purposes only and is not medical advice. Consult a qualified healthcare provider before starting, changing, or stopping any treatment for chronic migraine.